{"transactions":[{"id":1517072,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T20:02:12.000Z","date":"2024-05-14","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":16.98,"value":25470.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,947 restricted stock units."}],"balance_after":13738,"source":{"system":"sec-edgar","filing":"0001562180-24-004024","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218024004024/primarydocument.xml","form_type":"4"}},{"id":1552845,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-02T20:00:40.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10124,"derivative":{"exercise_price":12.86,"exercise_date":"2023-12-31","expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001562180-24-003148","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218024003148/primarydocument.xml","form_type":"4"}},{"id":1552844,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-02T20:00:40.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":23.5,"value":23500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,461 restricted stock units."}],"balance_after":15238,"source":{"system":"sec-edgar","filing":"0001562180-24-003148","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218024003148/primarydocument.xml","form_type":"4"}},{"id":1552843,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-02T20:00:40.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":12.86,"value":12860.0,"ownership":{"direct":true},"balance_after":16238,"source":{"system":"sec-edgar","filing":"0001562180-24-003148","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218024003148/primarydocument.xml","form_type":"4"}},{"id":1571995,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true}}],"security":"Option (right to buy)","published_at":"2024-03-18T16:30:56.000Z","date":"2024-03-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1904,"price":92.3,"value":175739.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 18, 2024, Bristol-Myers Squibb Company (\"Bristol-Myers\") acquired Karuna Therapeutics, Inc. (the \"Issuer\") pursuant to a certain Agreement and Plan of Merger, dated as of December 22, 2023 (the \"Merger Agreement\"), by and among the Issuer, Bristol-Myers and Miramar Merger Sub Inc., a wholly owned subsidiary of Bristol-Myers (\"Merger Sub\"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the \"Merger\") with the Issuer surviving the Merger as a wholly owned subsidiary of Bristol-Myers. At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock, $0.0001 par value per share (the \"Common Stock\") (other than certain excluded shares of Common Stock) automatically converted into the right to receive $330.00 per share in cash (the \"Merger Consideration\"), without interest and subject to applicable withholding tax."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, outstanding and unexercised options to purchase shares of Common Stock (the \"Options\"), whether granted under an Issuer stock plan or otherwise, automatically vested (to the extent not previously vested), were cancelled and entitled the holder to receive a one-time lump sum payment in an amount in cash, without interest and subject to deduction for any required tax withholding, equal to (i) the total number of shares of Common Stock subject to such Option multiplied by (ii) the excess, if any, of the Merger Consideration over the exercise price per share of Common Stock under such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, outstanding and unexercised options to purchase shares of Common Stock (the \"Options\"), whether granted under an Issuer stock plan or otherwise, automatically vested (to the extent not previously vested), were cancelled and entitled the holder to receive a one-time lump sum payment in an amount in cash, without interest and subject to deduction for any required tax withholding, equal to (i) the total number of shares of Common Stock subject to such Option multiplied by (ii) the excess, if any, of the Merger Consideration over the exercise price per share of Common Stock under such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These Options originally provided for vesting upon the earlier of (i) June 20, 2024, and (ii) the 2024 annual meeting of the Issuer's stockholders, subject to continued service through such date."}],"balance_after":0,"derivative":{"exercise_price":237.7,"expiration_date":"2033-06-19","underlying":"Common Stock","underlying_shares":1904},"source":{"system":"sec-edgar","filing":"0001140361-24-013931","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000114036124013931/form4.xml","form_type":"4"}},{"id":1571994,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true}}],"security":"Option (right to buy)","published_at":"2024-03-18T16:30:56.000Z","date":"2024-03-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5000,"price":227.04,"value":1135200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 18, 2024, Bristol-Myers Squibb Company (\"Bristol-Myers\") acquired Karuna Therapeutics, Inc. (the \"Issuer\") pursuant to a certain Agreement and Plan of Merger, dated as of December 22, 2023 (the \"Merger Agreement\"), by and among the Issuer, Bristol-Myers and Miramar Merger Sub Inc., a wholly owned subsidiary of Bristol-Myers (\"Merger Sub\"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the \"Merger\") with the Issuer surviving the Merger as a wholly owned subsidiary of Bristol-Myers. At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock, $0.0001 par value per share (the \"Common Stock\") (other than certain excluded shares of Common Stock) automatically converted into the right to receive $330.00 per share in cash (the \"Merger Consideration\"), without interest and subject to applicable withholding tax."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, outstanding and unexercised options to purchase shares of Common Stock (the \"Options\"), whether granted under an Issuer stock plan or otherwise, automatically vested (to the extent not previously vested), were cancelled and entitled the holder to receive a one-time lump sum payment in an amount in cash, without interest and subject to deduction for any required tax withholding, equal to (i) the total number of shares of Common Stock subject to such Option multiplied by (ii) the excess, if any, of the Merger Consideration over the exercise price per share of Common Stock under such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, outstanding and unexercised options to purchase shares of Common Stock (the \"Options\"), whether granted under an Issuer stock plan or otherwise, automatically vested (to the extent not previously vested), were cancelled and entitled the holder to receive a one-time lump sum payment in an amount in cash, without interest and subject to deduction for any required tax withholding, equal to (i) the total number of shares of Common Stock subject to such Option multiplied by (ii) the excess, if any, of the Merger Consideration over the exercise price per share of Common Stock under such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These Options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":102.96,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001140361-24-013931","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000114036124013931/form4.xml","form_type":"4"}},{"id":1571993,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true}}],"security":"Option (right to buy)","published_at":"2024-03-18T16:30:56.000Z","date":"2024-03-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8500,"price":201.99,"value":1716915.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 18, 2024, Bristol-Myers Squibb Company (\"Bristol-Myers\") acquired Karuna Therapeutics, Inc. (the \"Issuer\") pursuant to a certain Agreement and Plan of Merger, dated as of December 22, 2023 (the \"Merger Agreement\"), by and among the Issuer, Bristol-Myers and Miramar Merger Sub Inc., a wholly owned subsidiary of Bristol-Myers (\"Merger Sub\"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the \"Merger\") with the Issuer surviving the Merger as a wholly owned subsidiary of Bristol-Myers. At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock, $0.0001 par value per share (the \"Common Stock\") (other than certain excluded shares of Common Stock) automatically converted into the right to receive $330.00 per share in cash (the \"Merger Consideration\"), without interest and subject to applicable withholding tax."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, outstanding and unexercised options to purchase shares of Common Stock (the \"Options\"), whether granted under an Issuer stock plan or otherwise, automatically vested (to the extent not previously vested), were cancelled and entitled the holder to receive a one-time lump sum payment in an amount in cash, without interest and subject to deduction for any required tax withholding, equal to (i) the total number of shares of Common Stock subject to such Option multiplied by (ii) the excess, if any, of the Merger Consideration over the exercise price per share of Common Stock under such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, outstanding and unexercised options to purchase shares of Common Stock (the \"Options\"), whether granted under an Issuer stock plan or otherwise, automatically vested (to the extent not previously vested), were cancelled and entitled the holder to receive a one-time lump sum payment in an amount in cash, without interest and subject to deduction for any required tax withholding, equal to (i) the total number of shares of Common Stock subject to such Option multiplied by (ii) the excess, if any, of the Merger Consideration over the exercise price per share of Common Stock under such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These Options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":128.01,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001140361-24-013931","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000114036124013931/form4.xml","form_type":"4"}},{"id":1571992,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true}}],"security":"Option (right to buy)","published_at":"2024-03-18T16:30:56.000Z","date":"2024-03-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13000,"price":245.14,"value":3186820.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 18, 2024, Bristol-Myers Squibb Company (\"Bristol-Myers\") acquired Karuna Therapeutics, Inc. (the \"Issuer\") pursuant to a certain Agreement and Plan of Merger, dated as of December 22, 2023 (the \"Merger Agreement\"), by and among the Issuer, Bristol-Myers and Miramar Merger Sub Inc., a wholly owned subsidiary of Bristol-Myers (\"Merger Sub\"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the \"Merger\") with the Issuer surviving the Merger as a wholly owned subsidiary of Bristol-Myers. At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock, $0.0001 par value per share (the \"Common Stock\") (other than certain excluded shares of Common Stock) automatically converted into the right to receive $330.00 per share in cash (the \"Merger Consideration\"), without interest and subject to applicable withholding tax."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, outstanding and unexercised options to purchase shares of Common Stock (the \"Options\"), whether granted under an Issuer stock plan or otherwise, automatically vested (to the extent not previously vested), were cancelled and entitled the holder to receive a one-time lump sum payment in an amount in cash, without interest and subject to deduction for any required tax withholding, equal to (i) the total number of shares of Common Stock subject to such Option multiplied by (ii) the excess, if any, of the Merger Consideration over the exercise price per share of Common Stock under such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, outstanding and unexercised options to purchase shares of Common Stock (the \"Options\"), whether granted under an Issuer stock plan or otherwise, automatically vested (to the extent not previously vested), were cancelled and entitled the holder to receive a one-time lump sum payment in an amount in cash, without interest and subject to deduction for any required tax withholding, equal to (i) the total number of shares of Common Stock subject to such Option multiplied by (ii) the excess, if any, of the Merger Consideration over the exercise price per share of Common Stock under such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These Options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":84.86,"expiration_date":"2030-08-11","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001140361-24-013931","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000114036124013931/form4.xml","form_type":"4"}},{"id":1571991,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-03-18T16:30:56.000Z","date":"2024-03-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":990,"price":330,"value":326700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 18, 2024, Bristol-Myers Squibb Company (\"Bristol-Myers\") acquired Karuna Therapeutics, Inc. (the \"Issuer\") pursuant to a certain Agreement and Plan of Merger, dated as of December 22, 2023 (the \"Merger Agreement\"), by and among the Issuer, Bristol-Myers and Miramar Merger Sub Inc., a wholly owned subsidiary of Bristol-Myers (\"Merger Sub\"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the \"Merger\") with the Issuer surviving the Merger as a wholly owned subsidiary of Bristol-Myers. At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock, $0.0001 par value per share (the \"Common Stock\") (other than certain excluded shares of Common Stock) automatically converted into the right to receive $330.00 per share in cash (the \"Merger Consideration\"), without interest and subject to applicable withholding tax."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents restricted stock units (\"RSUs\"), each representing a contingent right to receive one share of Common Stock. Pursuant to the Merger Agreement, each outstanding RSU, whether granted under an Issuer stock plan or otherwise, automatically vested (to the extent not previously vested), was cancelled and entitled the holder to receive a one-time lump sum payment in an amount in cash, without interest and subject to deduction for any required tax withholding, equal to (i) the total number of shares of Common Stock subject to such RSU immediately prior to the effective time of the Merger, multiplied by (ii) the Merger Consideration."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units (\"RSUs\"), each representing a contingent right to receive one share of Common Stock. Pursuant to the Merger Agreement, each outstanding RSU, whether granted under an Issuer stock plan or otherwise, automatically vested (to the extent not previously vested), was cancelled and entitled the holder to receive a one-time lump sum payment in an amount in cash, without interest and subject to deduction for any required tax withholding, equal to (i) the total number of shares of Common Stock subject to such RSU immediately prior to the effective time of the Merger, multiplied by (ii) the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents restricted stock units (\"RSUs\"), each representing a contingent right to receive one share of Common Stock. Pursuant to the Merger Agreement, each outstanding RSU, whether granted under an Issuer stock plan or otherwise, automatically vested (to the extent not previously vested), was cancelled and entitled the holder to receive a one-time lump sum payment in an amount in cash, without interest and subject to deduction for any required tax withholding, equal to (i) the total number of shares of Common Stock subject to such RSU immediately prior to the effective time of the Merger, multiplied by (ii) the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-24-013931","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000114036124013931/form4.xml","form_type":"4"}},{"id":1640661,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-15T22:52:18.000Z","date":"2024-02-14","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":24.35,"value":36525.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,461 restricted stock units."}],"balance_after":15238,"source":{"system":"sec-edgar","filing":"0001562180-24-001341","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218024001341/primarydocument.xml","form_type":"4"}},{"id":1687157,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T21:09:40.000Z","date":"2024-01-02","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11124,"derivative":{"exercise_price":12.86,"exercise_date":"2023-12-31","expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001562180-24-000234","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218024000234/primarydocument.xml","form_type":"4"}},{"id":1687156,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T21:09:40.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":6412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents non-qualified stock option to purchase 6,412 shares of common stock granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy."}],"balance_after":6412,"derivative":{"exercise_price":27.15,"exercise_date":"2024-12-31","expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":6412},"source":{"system":"sec-edgar","filing":"0001562180-24-000234","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218024000234/primarydocument.xml","form_type":"4"}},{"id":1687155,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T21:09:40.000Z","date":"2024-01-02","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":26.91,"value":26910.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,461 restricted stock units."}],"balance_after":16738,"source":{"system":"sec-edgar","filing":"0001562180-24-000234","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218024000234/primarydocument.xml","form_type":"4"}},{"id":1687154,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T21:09:40.000Z","date":"2024-01-02","kind":"exercise","planned":false,"acquired":true,"shares":1000,"price":12.86,"value":12860.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,461 restricted stock units."}],"balance_after":17738,"source":{"system":"sec-edgar","filing":"0001562180-24-000234","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218024000234/primarydocument.xml","form_type":"4"}},{"id":1687153,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T21:09:40.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":2947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest as to 100% of the shares on December 31, 2024 granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,461 restricted stock units."}],"balance_after":16738,"source":{"system":"sec-edgar","filing":"0001562180-24-000234","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218024000234/primarydocument.xml","form_type":"4"}},{"id":1741987,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-14T21:09:11.000Z","date":"2023-11-14","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":21.89,"value":32835.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,597 restricted stock units."}],"balance_after":13791,"source":{"system":"sec-edgar","filing":"0001562180-23-007670","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218023007670/primarydocument.xml","form_type":"4"}},{"id":1835263,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-07-05T16:49:05.000Z","date":"2023-07-03","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests and becomes exercisable in thirty-six equal monthly installments beginning on August 12, 2020."}],"balance_after":13000,"derivative":{"exercise_price":84.86,"expiration_date":"2030-08-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000950170-23-031696","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000095017023031696/ownership.xml","form_type":"4"}},{"id":1835262,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-05T16:49:05.000Z","date":"2023-07-03","kind":"sale","planned":true,"acquired":false,"shares":400,"price":216.03,"value":86412.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.70 to $216.43, inclusive."}],"balance_after":990,"source":{"system":"sec-edgar","filing":"0000950170-23-031696","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000095017023031696/ownership.xml","form_type":"4"}},{"id":1835261,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-05T16:49:05.000Z","date":"2023-07-03","kind":"sale","planned":true,"acquired":false,"shares":600,"price":215.4,"value":129240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.70 to $215.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) through (3) to this Form 4."}],"balance_after":1390,"source":{"system":"sec-edgar","filing":"0000950170-23-031696","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000095017023031696/ownership.xml","form_type":"4"}},{"id":1835260,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-05T16:49:05.000Z","date":"2023-07-03","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":84.86,"value":84860.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2022."}],"balance_after":1990,"source":{"system":"sec-edgar","filing":"0000950170-23-031696","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000095017023031696/ownership.xml","form_type":"4"}},{"id":1846190,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-06-22T16:07:20.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":1904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest in full upon the earlier of (i) June 20, 2024, and (ii) the 2024 annual meeting of the Issuer's stockholders, subject to continued service through such dates."}],"balance_after":1904,"derivative":{"exercise_price":237.7,"expiration_date":"2033-06-19","underlying":"Common Stock","underlying_shares":1904},"source":{"system":"sec-edgar","filing":"0000950170-23-029400","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000095017023029400/ownership.xml","form_type":"4"}},{"id":1846189,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-22T16:07:20.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Comprised of restricted stock units (\"RSUs\"), each representing a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full upon the earlier of (i) June 20, 2024, and (ii) the 2024 annual meeting of the Issuer's stockholders, subject to continued service through such dates."}],"balance_after":990,"source":{"system":"sec-edgar","filing":"0000950170-23-029400","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000095017023029400/ownership.xml","form_type":"4"}},{"id":1924605,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-04-05T16:55:24.000Z","date":"2023-04-03","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable in thirty-six equal monthly installments beginning on August 12, 2020."}],"balance_after":14000,"derivative":{"exercise_price":84.86,"expiration_date":"2030-08-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000899243-23-010761","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000089924323010761/doc4.xml","form_type":"4"}},{"id":1924604,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-05T16:55:24.000Z","date":"2023-04-03","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":181.02,"value":181020.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2022."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-010761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000089924323010761/doc4.xml","form_type":"4"}},{"id":1924603,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-05T16:55:24.000Z","date":"2023-04-03","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":84.86,"value":84860.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2022."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0000899243-23-010761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000089924323010761/doc4.xml","form_type":"4"}},{"id":2061785,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-01-05T16:39:14.000Z","date":"2023-01-03","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable in thirty-six equal monthly installments beginning on August 12, 2020."}],"balance_after":15000,"derivative":{"exercise_price":84.86,"expiration_date":"2030-08-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001593968-23-000078","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396823000078/primary_01.xml","form_type":"4"}},{"id":2061784,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T16:39:14.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":1000,"price":197.48,"value":197480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2022."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001593968-23-000078","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396823000078/primary_01.xml","form_type":"4"}},{"id":2061783,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T16:39:14.000Z","date":"2023-01-03","kind":"exercise","acquired":true,"shares":1000,"price":84.86,"value":84860.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001593968-23-000078","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396823000078/primary_01.xml","form_type":"4"}},{"id":2066085,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-04T21:03:39.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":12124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents non-qualified stock option to purchase 12,124 shares of common stock granted pursuant to the Quanterix Corporation Amended and Restated 2018 Non-Employee Director Compensation Policy."}],"balance_after":12124,"derivative":{"exercise_price":12.86,"exercise_date":"2023-12-31","expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":12124},"source":{"system":"sec-edgar","filing":"0001562180-23-000098","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218023000098/primarydocument.xml","form_type":"4"}},{"id":2066084,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T21:03:39.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":8083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest as to 100% of the shares on December 31, 2023 granted pursuant to the Quanterix Corporation Amended and Restated 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 11,110 restricted stock units."}],"balance_after":15291,"source":{"system":"sec-edgar","filing":"0001562180-23-000098","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218023000098/primarydocument.xml","form_type":"4"}},{"id":2138216,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2022-10-12T17:13:03.000Z","date":"2022-10-11","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable in thirty-six equal monthly installments beginning on August 12, 2020."}],"balance_after":16000,"derivative":{"exercise_price":84.86,"expiration_date":"2030-08-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001593968-22-001514","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396822001514/primary_01.xml","form_type":"4"}},{"id":2138215,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-12T17:13:03.000Z","date":"2022-10-11","kind":"sale","acquired":false,"shares":1000,"price":205.63,"value":205630.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2022."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001593968-22-001514","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396822001514/primary_01.xml","form_type":"4"}},{"id":2138214,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-12T17:13:03.000Z","date":"2022-10-11","kind":"exercise","acquired":true,"shares":1000,"price":84.86,"value":84860.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001593968-22-001514","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396822001514/primary_01.xml","form_type":"4"}},{"id":2138130,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2022-10-12T17:04:45.000Z","date":"2022-08-15","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable in thirty-six equal monthly installments beginning on August 12, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4/A amends the Form 4 filed by the reporting person on August 16, 2022 (the \"Original Form 4\"), which inadvertently reported the incorrect number of securities in column 9 of Table II. This Form 4/A is being filed solely to correct the number of securities reported in column 9 of Table II. No other amendments or changes have been made to the Original Form 4."}],"balance_after":17000,"derivative":{"exercise_price":84.86,"expiration_date":"2030-08-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001593968-22-001512","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396822001512/primary_01.xml","form_type":"4/A","original_submission_date":"2022-08-16"}},{"id":2183690,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2022-08-16T16:08:45.000Z","date":"2022-08-15","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable in thirty-six equal monthly installments beginning on August 12, 2020."}],"balance_after":8667,"derivative":{"exercise_price":84.86,"expiration_date":"2030-08-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001593968-22-001343","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396822001343/primary_01.xml","form_type":"4"}},{"id":2183689,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-16T16:08:45.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":1000,"price":267.59,"value":267590.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 6, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001593968-22-001343","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396822001343/primary_01.xml","form_type":"4"}},{"id":2183688,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-16T16:08:45.000Z","date":"2022-08-15","kind":"exercise","acquired":true,"shares":1000,"price":84.86,"value":84860.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001593968-22-001343","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396822001343/primary_01.xml","form_type":"4"}},{"id":2229547,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2022-06-16T16:38:08.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier of (i) June 15, 2023, and (ii) the 2023 annual meeting of the Issuer's stockholders."}],"balance_after":5000,"derivative":{"exercise_price":102.96,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001593968-22-001148","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396822001148/primary_01.xml","form_type":"4"}},{"id":2250903,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2022-05-31T16:45:16.000Z","date":"2022-05-27","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable in thirty-six equal monthly installments beginning on August 12, 2020."}],"balance_after":18000,"derivative":{"exercise_price":84.86,"expiration_date":"2030-08-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001593968-22-001053","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396822001053/primary_01.xml","form_type":"4"}},{"id":2250902,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-31T16:45:16.000Z","date":"2022-05-27","kind":"sale","acquired":false,"shares":1000,"price":110,"value":110000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 6, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001593968-22-001053","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396822001053/primary_01.xml","form_type":"4"}},{"id":2250901,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-31T16:45:16.000Z","date":"2022-05-27","kind":"exercise","acquired":true,"shares":1000,"price":84.86,"value":84860.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001593968-22-001053","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396822001053/primary_01.xml","form_type":"4"}},{"id":2387559,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2022-02-17T17:16:09.000Z","date":"2022-02-15","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable in thirty-six equal monthly installments beginning on August 12, 2020."}],"balance_after":19000,"derivative":{"exercise_price":84.86,"expiration_date":"2030-08-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001593968-22-000493","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396822000493/primary_01.xml","form_type":"4"}},{"id":2387558,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-17T17:16:09.000Z","date":"2022-02-15","kind":"sale","acquired":false,"shares":1000,"price":110,"value":110000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001593968-22-000493","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396822000493/primary_01.xml","form_type":"4"}},{"id":2387557,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-17T17:16:09.000Z","date":"2022-02-15","kind":"exercise","acquired":true,"shares":1000,"price":84.86,"value":84860.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001593968-22-000493","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396822000493/primary_01.xml","form_type":"4"}},{"id":2442980,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-05T21:05:11.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":4002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents non-qualified stock option to purchase 4,002 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy."}],"balance_after":4002,"derivative":{"exercise_price":42.41,"exercise_date":"2022-12-31","expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":4002},"source":{"system":"sec-edgar","filing":"0001562180-22-000224","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218022000224/primarydocument.xml","form_type":"4"}},{"id":2442979,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:05:11.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":2668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest as to 100% of the shares on December 31, 2022 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,208 restricted stock units."}],"balance_after":7208,"source":{"system":"sec-edgar","filing":"0001562180-22-000224","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218022000224/primarydocument.xml","form_type":"4"}},{"id":2512336,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2021-11-15T16:48:31.000Z","date":"2021-11-15","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable in thirty-six equal monthly installments beginning on August 12, 2020."}],"balance_after":20000,"derivative":{"exercise_price":84.86,"expiration_date":"2030-08-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001593968-21-002386","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396821002386/primary_01.xml","form_type":"4"}},{"id":2512335,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-15T16:48:31.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":1000,"price":138.24,"value":138240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001593968-21-002386","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396821002386/primary_01.xml","form_type":"4"}},{"id":2512334,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-15T16:48:31.000Z","date":"2021-11-15","kind":"exercise","acquired":true,"shares":1000,"price":84.86,"value":84860.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001593968-21-002386","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396821002386/primary_01.xml","form_type":"4"}},{"id":2640607,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-06T20:15:58.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":104,"price":59.48,"value":6185.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the second quarter of 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Closing price of the Company's common stock on the Nasdaq Global Market on July 1, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 4,540 restricted stock units."}],"balance_after":4644,"source":{"system":"sec-edgar","filing":"0001562180-21-004769","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218021004769/primarydocument.xml","form_type":"4"}},{"id":2656823,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2021-06-23T16:30:42.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier of (i) June 16, 2022, and (ii) the 2022 annual meeting of the Issuer's stockholders."}],"balance_after":8500,"derivative":{"exercise_price":128.01,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001593968-21-001682","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396821001682/primary_01.xml","form_type":"4"}},{"id":2678810,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2021-06-07T17:51:50.000Z","date":"2021-06-07","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable in thirty-six equal monthly installments beginning on August 12, 2020."}],"balance_after":21000,"derivative":{"exercise_price":84.86,"expiration_date":"2030-08-11","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001593968-21-001562","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396821001562/primary_01.xml","form_type":"4"}},{"id":2678809,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-07T17:51:50.000Z","date":"2021-06-07","kind":"sale","acquired":false,"shares":4000,"price":112.93,"value":451720.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001593968-21-001562","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396821001562/primary_01.xml","form_type":"4"}},{"id":2678808,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-07T17:51:50.000Z","date":"2021-06-07","kind":"exercise","acquired":true,"shares":4000,"price":84.86,"value":339440.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001593968-21-001562","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000159396821001562/primary_01.xml","form_type":"4"}},{"id":2736999,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-28T21:18:43.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":15800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to one-third of the shares on April 27, 2022, and the remaining two-thirds of the shares vest monthly thereafter over two years in 24 successive equal installments."}],"balance_after":15800,"derivative":{"exercise_price":77.79,"expiration_date":"2031-04-27","underlying":"Common Stock","underlying_shares":15800},"source":{"system":"sec-edgar","filing":"0001562180-21-003003","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218021003003/primarydocument.xml","form_type":"4"}},{"id":2736998,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-28T21:18:43.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":4540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of stock issuable on vesting of restricted stock units. The restricted stock units vest as to one-third of shares on each of April 27, 2022, April 27, 2023 and April 27, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,540 restricted stock units."}],"balance_after":4540,"source":{"system":"sec-edgar","filing":"0001562180-21-003003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218021003003/primarydocument.xml","form_type":"4"}},{"id":3056947,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-14T16:26:38.000Z","date":"2020-08-12","kind":"grant","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in thirty-six equal monthly installments beginning on August 12, 2020."}],"balance_after":25000,"derivative":{"exercise_price":84.86,"expiration_date":"2030-08-11","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-20-022412","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553231/000089924320022412/doc4.xml","form_type":"4"}},{"id":412702,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2018-08-14T21:04:09.000Z","date":"2018-08-13","kind":"sale","acquired":false,"shares":10214,"price":41,"value":418774.0,"ownership":{"direct":true},"balance_after":72672,"source":{"system":"sec-edgar","filing":"0001225208-18-012551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520818012551/doc4.xml","form_type":"4"}},{"id":414177,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2018-06-08T17:11:10.000Z","date":"2018-06-06","kind":"sale","acquired":false,"shares":15758,"price":36.45,"value":574379.1,"ownership":{"direct":true},"balance_after":82886,"source":{"system":"sec-edgar","filing":"0001225208-18-010376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520818010376/doc4.xml","form_type":"4"}},{"id":414176,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2018-06-08T17:11:10.000Z","date":"2018-06-06","kind":"sale","acquired":false,"shares":3242,"price":36.46,"value":118203.32,"ownership":{"direct":true},"balance_after":98644,"source":{"system":"sec-edgar","filing":"0001225208-18-010376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520818010376/doc4.xml","form_type":"4"}},{"id":417458,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Stock Appreciation Rights","published_at":"2018-03-02T21:02:56.000Z","date":"2018-02-28","kind":"exercise","acquired":false,"shares":38546,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":27.37,"exercise_date":"2018-02-28","expiration_date":"2018-02-28","underlying":"Common Stock","underlying_shares":38546},"source":{"system":"sec-edgar","filing":"0001225208-18-005112","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520818005112/doc4.xml","form_type":"4"}},{"id":417457,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2018-03-02T21:02:56.000Z","date":"2018-02-28","kind":"tax_withholding","acquired":false,"shares":23397,"price":35.7,"value":835272.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used."}],"balance_after":101886,"source":{"system":"sec-edgar","filing":"0001225208-18-005112","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520818005112/doc4.xml","form_type":"4"}},{"id":417456,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2018-03-02T21:02:56.000Z","date":"2018-02-28","kind":"tax_withholding","acquired":false,"shares":7419,"price":36.31,"value":269383.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations and payment of exercise price in connection with the earn-out of stock appreciation rights (including dividend equivalents thereon)."}],"balance_after":125283,"source":{"system":"sec-edgar","filing":"0001225208-18-005112","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520818005112/doc4.xml","form_type":"4"}},{"id":417455,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2018-03-02T21:02:56.000Z","date":"2018-02-28","kind":"exercise","acquired":true,"shares":38546,"price":27.37,"value":1055004.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon)."}],"balance_after":132702,"source":{"system":"sec-edgar","filing":"0001225208-18-005112","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520818005112/doc4.xml","form_type":"4"}},{"id":417783,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2018-02-28T23:11:34.000Z","date":"2018-02-26","kind":"tax_withholding","acquired":false,"shares":7249,"price":37.09,"value":268865.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon)."}],"balance_after":94156,"source":{"system":"sec-edgar","filing":"0001225208-18-004669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520818004669/doc4.xml","form_type":"4"}},{"id":417782,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2018-02-28T23:11:34.000Z","date":"2018-02-26","kind":"grant","acquired":true,"shares":19847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon)."}],"balance_after":101405,"source":{"system":"sec-edgar","filing":"0001225208-18-004669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520818004669/doc4.xml","form_type":"4"}},{"id":417960,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Stock Appreciation Rights","published_at":"2018-02-28T00:53:28.000Z","date":"2018-02-24","kind":"exercise","acquired":false,"shares":15716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":18.9,"exercise_date":"2018-02-24","expiration_date":"2018-02-24","underlying":"Common Stock","underlying_shares":15716},"source":{"system":"sec-edgar","filing":"0001225208-18-004475","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520818004475/doc4.xml","form_type":"4"}},{"id":417959,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2018-02-28T00:53:28.000Z","date":"2018-02-24","kind":"tax_withholding","acquired":false,"shares":5015,"price":35.98,"value":180439.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used."}],"balance_after":81558,"source":{"system":"sec-edgar","filing":"0001225208-18-004475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520818004475/doc4.xml","form_type":"4"}},{"id":417958,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2018-02-28T00:53:28.000Z","date":"2018-02-24","kind":"tax_withholding","acquired":false,"shares":3649,"price":36.26,"value":132312.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Price is the closing price of Pfizer common stock on February 23, 2018"}],"balance_after":86573,"source":{"system":"sec-edgar","filing":"0001225208-18-004475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520818004475/doc4.xml","form_type":"4"}},{"id":417957,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2018-02-28T00:53:28.000Z","date":"2018-02-24","kind":"exercise","acquired":true,"shares":15716,"price":18.9,"value":297032.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon)."}],"balance_after":90222,"source":{"system":"sec-edgar","filing":"0001225208-18-004475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520818004475/doc4.xml","form_type":"4"}},{"id":418205,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Stock Appreciation Rights","published_at":"2018-02-23T20:54:19.000Z","date":"2018-02-22","kind":"grant","acquired":true,"shares":25064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."}],"balance_after":25064,"derivative":{"exercise_price":35.74,"exercise_date":"2025-02-22","expiration_date":"2025-02-22","underlying":"Common Stock","underlying_shares":25064},"source":{"system":"sec-edgar","filing":"0001225208-18-003978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520818003978/doc4.xml","form_type":"4"}},{"id":418204,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Stock Appreciation Rights","published_at":"2018-02-23T20:54:19.000Z","date":"2018-02-22","kind":"grant","acquired":true,"shares":29981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."}],"balance_after":29981,"derivative":{"exercise_price":35.74,"exercise_date":"2023-02-22","expiration_date":"2023-02-22","underlying":"Common Stock","underlying_shares":29981},"source":{"system":"sec-edgar","filing":"0001225208-18-003978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520818003978/doc4.xml","form_type":"4"}},{"id":423893,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2017-08-23T19:51:46.000Z","date":"2017-08-21","kind":"sale","acquired":false,"shares":8064,"price":32.7,"value":263692.8,"ownership":{"direct":true},"balance_after":74506,"source":{"system":"sec-edgar","filing":"0001225208-17-014287","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520817014287/doc4.xml","form_type":"4"}},{"id":429214,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2017-03-01T22:10:45.000Z","date":"2017-02-27","kind":"tax_withholding","acquired":false,"shares":2667,"price":34.28,"value":91424.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon)."}],"balance_after":82569,"source":{"system":"sec-edgar","filing":"0001225208-17-005109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520817005109/doc4.xml","form_type":"4"}},{"id":429213,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2017-03-01T22:10:45.000Z","date":"2017-02-27","kind":"tax_withholding","acquired":false,"shares":2638,"price":34.28,"value":90430.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon)."}],"balance_after":85236,"source":{"system":"sec-edgar","filing":"0001225208-17-005109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520817005109/doc4.xml","form_type":"4"}},{"id":429212,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2017-03-01T22:10:45.000Z","date":"2017-02-27","kind":"grant","acquired":true,"shares":7133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon)."}],"balance_after":87874,"source":{"system":"sec-edgar","filing":"0001225208-17-005109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520817005109/doc4.xml","form_type":"4"}},{"id":429437,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Stock Appreciation Rights","published_at":"2017-02-27T23:47:45.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":27965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."}],"balance_after":27965,"derivative":{"exercise_price":34.06,"exercise_date":"2024-02-23","expiration_date":"2024-02-23","underlying":"Common Stock","underlying_shares":27965},"source":{"system":"sec-edgar","filing":"0001225208-17-004781","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520817004781/doc4.xml","form_type":"4"}},{"id":429436,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Stock Appreciation Rights","published_at":"2017-02-27T23:47:45.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":33685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."}],"balance_after":33685,"derivative":{"exercise_price":34.06,"exercise_date":"2022-02-23","expiration_date":"2022-02-23","underlying":"Common Stock","underlying_shares":33685},"source":{"system":"sec-edgar","filing":"0001225208-17-004781","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520817004781/doc4.xml","form_type":"4"}},{"id":429435,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Stock Appreciation Rights","published_at":"2017-02-27T23:47:45.000Z","date":"2017-02-23","kind":"exercise","acquired":false,"shares":27306,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":21.03,"exercise_date":"2017-02-23","expiration_date":"2017-02-23","underlying":"Common Stock","underlying_shares":27306},"source":{"system":"sec-edgar","filing":"0001225208-17-004781","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520817004781/doc4.xml","form_type":"4"}},{"id":429434,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2017-02-27T23:47:45.000Z","date":"2017-02-23","kind":"tax_withholding","acquired":false,"shares":13220,"price":32.49,"value":429517.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used."}],"balance_after":80741,"source":{"system":"sec-edgar","filing":"0001225208-17-004781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520817004781/doc4.xml","form_type":"4"}},{"id":429433,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2017-02-27T23:47:45.000Z","date":"2017-02-23","kind":"tax_withholding","acquired":false,"shares":5263,"price":34.06,"value":179257.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights."}],"balance_after":93961,"source":{"system":"sec-edgar","filing":"0001225208-17-004781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520817004781/doc4.xml","form_type":"4"}},{"id":429432,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2017-02-27T23:47:45.000Z","date":"2017-02-23","kind":"exercise","acquired":true,"shares":27306,"price":21.03,"value":574245.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon)."}],"balance_after":99224,"source":{"system":"sec-edgar","filing":"0001225208-17-004781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520817004781/doc4.xml","form_type":"4"}},{"id":438379,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2016-05-12T12:21:24.000Z","date":"2016-05-11","kind":"sale","acquired":false,"shares":4700,"price":33.5,"value":157450.0,"ownership":{"direct":true},"balance_after":71659,"source":{"system":"sec-edgar","filing":"0001225208-16-033182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520816033182/doc4.xml","form_type":"4"}},{"id":441108,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2016-03-02T00:13:51.000Z","date":"2016-02-28","kind":"tax_withholding","acquired":false,"shares":2670,"price":30.23,"value":80714.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon)."}],"balance_after":76359,"source":{"system":"sec-edgar","filing":"0001225208-16-028812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520816028812/doc4.xml","form_type":"4"}},{"id":441107,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2016-03-02T00:13:51.000Z","date":"2016-02-28","kind":"tax_withholding","acquired":false,"shares":1333,"price":30.23,"value":40296.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon)."}],"balance_after":79029,"source":{"system":"sec-edgar","filing":"0001225208-16-028812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520816028812/doc4.xml","form_type":"4"}},{"id":441106,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2016-03-02T00:13:51.000Z","date":"2016-02-28","kind":"grant","acquired":true,"shares":3603,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon)."}],"balance_after":80362,"source":{"system":"sec-edgar","filing":"0001225208-16-028812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520816028812/doc4.xml","form_type":"4"}},{"id":441354,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Stock Appreciation Rights","published_at":"2016-02-26T20:05:24.000Z","date":"2016-02-25","kind":"grant","acquired":true,"shares":31972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."}],"balance_after":31972,"derivative":{"exercise_price":30.59,"exercise_date":"2023-02-25","expiration_date":"2023-02-25","underlying":"Common Stock","underlying_shares":31972},"source":{"system":"sec-edgar","filing":"0001225208-16-028384","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520816028384/doc4.xml","form_type":"4"}},{"id":441353,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Stock Appreciation Rights","published_at":"2016-02-26T20:05:24.000Z","date":"2016-02-25","kind":"grant","acquired":true,"shares":35776,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."}],"balance_after":35776,"derivative":{"exercise_price":30.59,"exercise_date":"2021-02-25","expiration_date":"2021-02-25","underlying":"Common Stock","underlying_shares":35776},"source":{"system":"sec-edgar","filing":"0001225208-16-028384","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520816028384/doc4.xml","form_type":"4"}},{"id":441352,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Stock Appreciation Rights","published_at":"2016-02-26T20:05:24.000Z","date":"2016-02-24","kind":"exercise","acquired":false,"shares":18984,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":18.9,"exercise_date":"2016-02-24","expiration_date":"2016-02-24","underlying":"Common Stock","underlying_shares":18984},"source":{"system":"sec-edgar","filing":"0001225208-16-028384","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520816028384/doc4.xml","form_type":"4"}},{"id":441351,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2016-02-26T20:05:24.000Z","date":"2016-02-24","kind":"tax_withholding","acquired":false,"shares":8958,"price":29.67,"value":265783.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used."}],"balance_after":76759,"source":{"system":"sec-edgar","filing":"0001225208-16-028384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520816028384/doc4.xml","form_type":"4"}},{"id":441350,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2016-02-26T20:05:24.000Z","date":"2016-02-24","kind":"tax_withholding","acquired":false,"shares":3750,"price":30.02,"value":112575.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights."}],"balance_after":85717,"source":{"system":"sec-edgar","filing":"0001225208-16-028384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520816028384/doc4.xml","form_type":"4"}},{"id":441349,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2016-02-26T20:05:24.000Z","date":"2016-02-24","kind":"exercise","acquired":true,"shares":18984,"price":18.9,"value":358797.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon)."}],"balance_after":89467,"source":{"system":"sec-edgar","filing":"0001225208-16-028384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520816028384/doc4.xml","form_type":"4"}},{"id":449831,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2015-06-12T13:26:48.000Z","date":"2015-06-11","kind":"exercise","acquired":false,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":25.87,"expiration_date":"2017-02-21","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001225208-15-013736","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520815013736/doc4.xml","form_type":"4"}},{"id":449830,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2015-06-12T13:26:48.000Z","date":"2015-06-11","kind":"sale","acquired":false,"shares":12100,"price":34.4,"value":416240.0,"ownership":{"direct":true},"balance_after":70113,"source":{"system":"sec-edgar","filing":"0001225208-15-013736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520815013736/doc4.xml","form_type":"4"}},{"id":449829,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2015-06-12T13:26:48.000Z","date":"2015-06-11","kind":"sale","acquired":false,"shares":6900,"price":34.38,"value":237222.0,"ownership":{"direct":true},"balance_after":82213,"source":{"system":"sec-edgar","filing":"0001225208-15-013736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520815013736/doc4.xml","form_type":"4"}},{"id":449828,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2015-06-12T13:26:48.000Z","date":"2015-06-11","kind":"sale","acquired":false,"shares":5500,"price":34.39,"value":189145.0,"ownership":{"direct":true},"balance_after":89113,"source":{"system":"sec-edgar","filing":"0001225208-15-013736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520815013736/doc4.xml","form_type":"4"}},{"id":449827,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2015-06-12T13:26:48.000Z","date":"2015-06-11","kind":"sale","acquired":false,"shares":900,"price":34.37,"value":30933.0,"ownership":{"direct":true},"balance_after":94613,"source":{"system":"sec-edgar","filing":"0001225208-15-013736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520815013736/doc4.xml","form_type":"4"}},{"id":449826,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2015-06-12T13:26:48.000Z","date":"2015-06-11","kind":"sale","acquired":false,"shares":500,"price":34.36,"value":17180.0,"ownership":{"direct":true},"balance_after":95513,"source":{"system":"sec-edgar","filing":"0001225208-15-013736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520815013736/doc4.xml","form_type":"4"}},{"id":449825,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2015-06-12T13:26:48.000Z","date":"2015-06-11","kind":"sale","acquired":false,"shares":100,"price":34.35,"value":3435.0,"ownership":{"direct":true},"balance_after":96013,"source":{"system":"sec-edgar","filing":"0001225208-15-013736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520815013736/doc4.xml","form_type":"4"}},{"id":449824,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16065,"kind":"person","name":"OLSON LAURIE J","position":1,"cik":"0001553231","reported_name":"OLSON LAURIE J","relationship":{"officer":true,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2015-06-12T13:26:48.000Z","date":"2015-06-11","kind":"exercise","acquired":true,"shares":26000,"price":25.87,"value":672620.0,"ownership":{"direct":true},"balance_after":96113,"source":{"system":"sec-edgar","filing":"0001225208-15-013736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520815013736/doc4.xml","form_type":"4"}}],"next_cursor":"2015-06-12T13:26:48.000000Z,449824"}